A Comprehensive Review of the Current Evidence

Giulia Di Dalmazi,Cesidio Giuliani,Ines Bucci,Marco Mascitti,Giorgio Napolitano

DOI: https://doi.org/10.3390/ijms25105395

IF: 5.6

2024-05-16

International Journal of Molecular Sciences

Abstract:Thyroid cancer (TC) and thyroid autoimmune disorders (AITD) are among the most common diseases in the general population, with higher incidence in women. Chronic inflammation and autoimmunity play a pivotal role in carcinogenesis. Some studies, indeed, have pointed out the presence of AITD as a risk factor for TC, although this issue remains controversial. Prevention of autoimmune disease and cancer is the ultimate goal for clinicians and scientists, but it is not always feasible. Thus, new treatments, that overcome the current barriers to prevention and treatment of TC and AITD are needed. Alkaloids are secondary plant metabolites endowed with several biological activities including anticancer and immunomodulatory properties. In this perspective, alkaloids may represent a promising source of prophylactic and therapeutic agents for TC and AITD. This review encompasses the current published literature on alkaloids effects on TC and AITD, with a specific focus on the pathways involved in TC and AITD development and progression.

biochemistry & molecular biology,chemistry, multidisciplinary